...
机译:镰状细胞性疾病患儿急性胸部综合征的皮质类固醇:使用方法的变化及其与住院时间和再入院的关联性† sup>
Division of Hematology/Oncology, Children's Hospital Boston, Boston, Massachusetts|Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts|Department of Pediatrics, Harvard Medical School, Boston, Massachusetts|Harvard Pediatric Health Services Research Fellowship, Boston, Massachusetts;
Department of Pediatrics, Harvard Medical School, Boston, Massachusetts|Clinical Research Program, Children's Hospital Boston, Boston, Massachusetts;
Division of Hematology/Oncology, Children's Hospital Boston, Boston, Massachusetts|Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts|Department of Pediatrics, Harvard Medical School, Boston, Massachusetts;
Division of Hematology/Oncology, Children's Hospital Boston, Boston, Massachusetts|Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts|Department of Pediatrics, Harvard Medical School, Boston, Massachusetts;
机译:镰状细胞性疾病患儿急性胸部综合征的皮质类固醇:使用方法的变化以及与住院时间和再入院的关联。
机译:勘误表:Sobota等人,Am J Hematol,2010 DOI号21565,“镰状细胞疾病患儿的急性胸部综合征的皮质类固醇:使用方法的变化以及与住院时间和再入院时间的关系”
机译:镰状细胞病患儿的急性胸综合症后使用皮质类固醇和再次入院的风险增加。
机译:在未解决的急性呼吸窘迫综合征中延长皮质类固醇治疗的生物疗效证据
机译:急性胸部综合征和哮喘的镰状细胞患者一氧化氮途径候选基因的多态性。
机译:皮质类固醇激素与镰状细胞病小儿急性胸部综合征:在使用变化和关联与住宿和再住院的长度
机译:抗生素选择与医院住院时间和镰状细胞疾病患者入住危险因素的危险因素和急性胸部综合征:观察队列研究